Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Early diagnosis of venous thromboembolism as a clinical primary symptom of occult cancer: Core proteins of a venous thrombus.

Wen S, Duan Q, Yang F, Li G, Wang L.

Oncol Lett. 2017 Jul;14(1):491-496. doi: 10.3892/ol.2017.6175. Epub 2017 May 16.

2.

Cancer and Venous Thromboembolic Disease: A Review.

Donnellan E, Khorana AA.

Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7.

PMID:
28174293
3.
4.

Is DVT prophylaxis necessary after oncology lower limb surgery? A pilot study.

Singh VA, Yong LM, Vijayananthan A.

Springerplus. 2016 Jun 30;5(1):943. doi: 10.1186/s40064-016-2441-9. eCollection 2016.

5.

Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.

Bouée S, Emery C, Samson A, Gourmelen J, Bailly C, Cotté FE.

Thromb J. 2016 Feb 19;14:4. doi: 10.1186/s12959-016-0078-0. eCollection 2016.

6.

The origin and onset of acute venous thrombus.

Wang L, Duan Q, Yang F, Wen S.

Int J Clin Exp Med. 2015 Nov 15;8(11):19804-14. eCollection 2015. Review.

7.

Deep Vein Thrombosis in Patients with Severe Motor and Intellectual Disabilities, Especially Diagnosis and Prevention of Recurrence for Chronic Thrombosis-Serial Changes of Sonography and D-Dimer.

Ohmori H, Kanaoka Y, Murata Y, Yamasaki M, Takesue H, Matsumoto N, Sumimoto R, Ohgi S.

Ann Vasc Dis. 2015;8(4):290-6. doi: 10.3400/avd.oa.15-00102. Epub 2015 Oct 16.

8.

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S.

PLoS One. 2015 Dec 30;10(12):e0144856. doi: 10.1371/journal.pone.0144856. eCollection 2015. Review.

9.

Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.

Haighton M, Kempen DH, Wolterbeek N, Marting LN, van Dijk M, Veen RM.

J Orthop Surg Res. 2015 Sep 17;10:145. doi: 10.1186/s13018-015-0285-6.

10.

Increased Expressions of Integrin Subunit β1, β2 and β3 in Patients with Acute Infection.

Song Y, Wang L, Yang F, Wu X, Duan Q, Gong Z.

Int J Med Sci. 2015 Jul 25;12(8):639-43. doi: 10.7150/ijms.11857. eCollection 2015.

11.

Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis.

Palamaner Subash Shantha G, Kumar AA, Sethi M, Khanna RC, Pancholy SB.

PeerJ. 2015 Mar 10;3:e835. doi: 10.7717/peerj.835. eCollection 2015. Review.

12.

Increased expressions of integrin subunit β1, β2 and β3 in patients with venous thromboembolism: new markers for venous thromboembolism.

Song Y, Yang F, Wang L, Duan Q, Jin Y, Gong Z.

Int J Clin Exp Med. 2014 Sep 15;7(9):2578-84. eCollection 2014.

13.

Relationship of high CH50 level and interruption of cascade reaction of complement mRNA expression in acute venous thromboembolism patients.

Wen S, Yang F, Wang L, Duan Q, Gong Z, Lv W.

Int J Clin Exp Med. 2014 Aug 15;7(8):2351-4. eCollection 2014.

14.

Evidence-based guidance on venous thromboembolism in patients with solid tumours.

Shea-Budgell MA, Wu CM, Easaw JC.

Curr Oncol. 2014 Jun;21(3):e504-14. doi: 10.3747/co.21.1938.

15.

Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.

Donnellan E, Kevane B, Bird BR, Ainle FN.

Curr Oncol. 2014 Jun;21(3):134-43. doi: 10.3747/co.21.1864. Review.

16.

Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA.

Am J Med. 2014 Sep;127(9):829-39.e5. doi: 10.1016/j.amjmed.2014.03.041. Epub 2014 May 6.

17.

Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis.

Wang LM, Duan QL, Yang F, Yi XH, Zeng Y, Tian HY, Lv W, Jin Y.

Int J Clin Exp Med. 2014 Mar 15;7(3):566-72. eCollection 2014.

18.

Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines.

Bang SM, Jang MJ, Kim KH, Yhim HY, Kim YK, Nam SH, Hwang HG, Bae SH, Kim SH, Mun YC, Kim YK, Kim I, Choi WI, Jung CW, Park NH, Choi NK, Park BJ, Oh D; Korean Society of Thrombosis and Hemostasis.

J Korean Med Sci. 2014 Feb;29(2):164-71. doi: 10.3346/jkms.2014.29.2.164. Epub 2014 Jan 28.

19.

Deep vein thrombosis in patients with severe motor and intellectual disabilities.

Ohmori H, Ochi F, Tanuma N, Ohnuki E, Yamasaki M, Takesue H, Kan M, Matsumoto N, Sumimoto R, Harada A.

Ann Vasc Dis. 2013;6(4):694-701. doi: 10.3400/avd.oa.13-00090. Epub 2013 Nov 15.

20.

Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.

Kinov P, Tanchev PP, Ellis M, Volpin G.

Int Orthop. 2014 Jan;38(1):169-75. doi: 10.1007/s00264-013-2134-8. Epub 2013 Oct 11. Review.

Supplemental Content

Support Center